39 related articles for article (PubMed ID: 10914741)
1. Colon cancer cell vaccine prepared with replication-deficient vaccinia viruses encoding B7.1 and interleukin-2 induce antitumor response in syngeneic mice.
Sivanandham M; Shaw P; Bernik SF; Paoletti E; Wallack MK
Cancer Immunol Immunother; 1998 Jul; 46(5):261-7. PubMed ID: 9690454
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-2 secretion by KHT sarcoma cells leads to loss of their vaccine potential.
Hsu SC; Glaves D; Sood AK
Cancer Immunol Immunother; 1997 Apr; 44(2):117-24. PubMed ID: 9177474
[TBL] [Abstract][Full Text] [Related]
3. Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines.
Zuiverloon TCM; de Jong FC; Costello JC; Theodorescu D
Bladder Cancer; 2018 Apr; 4(2):169-183. PubMed ID: 29732388
[TBL] [Abstract][Full Text] [Related]
4. Effects of cartilage oligomeric matrix protein on bone morphogenetic protein-2-induced differentiation of mesenchymal stem cells.
Guo P; Shi ZL; Liu A; Lin T; Bi F; Shi M; Yan SG
Orthop Surg; 2014 Nov; 6(4):280-7. PubMed ID: 25430711
[TBL] [Abstract][Full Text] [Related]
5. Cartilage oligomeric matrix protein gene multilayers inhibit osteogenic differentiation and promote chondrogenic differentiation of mesenchymal stem cells.
Guo P; Shi ZL; Liu A; Lin T; Bi FG; Shi MM; Yan SG
Int J Mol Sci; 2014 Nov; 15(11):20117-33. PubMed ID: 25380520
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology in urology.
Jin S; Labhasetwar V
Urol Clin North Am; 2009 May; 36(2):179-88, viii. PubMed ID: 19406319
[TBL] [Abstract][Full Text] [Related]
7. A synergistic antitumor effect of interleukin-2 addition with CD80 immunogene therapy for peritoneal metastasis of gastric carcinoma.
Kosaka K; Yashiro M; Sakate Y; Hirakawa K
Dig Dis Sci; 2007 Aug; 52(8):1946-53. PubMed ID: 17404853
[TBL] [Abstract][Full Text] [Related]
8. Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas.
Parney IF; Chang LJ; Farr-Jones MA; Hao C; Smylie M; Petruk KC
J Neurooncol; 2006 May; 78(1):71-80. PubMed ID: 16718522
[TBL] [Abstract][Full Text] [Related]
9. An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia.
Chan L; Hardwick NR; Guinn BA; Darling D; Gäken J; Galea-Lauri J; Ho AY; Mufti GJ; Farzaneh F
Cancer Immunol Immunother; 2006 Aug; 55(8):1017-24. PubMed ID: 16450142
[TBL] [Abstract][Full Text] [Related]
10. Immune gene therapy in urology.
Kausch I; Ardelt P; Böhle A; Ratliff TL
Curr Urol Rep; 2002 Feb; 3(1):82-9. PubMed ID: 12084224
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for urologic cancer.
Ferrer FA; Rodriguez R
Curr Urol Rep; 2002 Feb; 3(1):75-81. PubMed ID: 12084223
[TBL] [Abstract][Full Text] [Related]
12. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines.
Saito S; Bannerji R; Gansbacher B; Rosenthal FM; Romanenko P; Heston WD; Fair WR; Gilboa E
Cancer Res; 1994 Jul; 54(13):3516-20. PubMed ID: 8012975
[TBL] [Abstract][Full Text] [Related]
14. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-based gene therapy of human tumors. An overview.
Parmiani G; Arienti F; Sulé-Suso J; Melani C; Colombo MP; Ramakrishna V; Belli F; Mascheroni L; Rivoltini L; Cascinelli N
Folia Biol (Praha); 1996; 42(6):305-9. PubMed ID: 9158940
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer.
Larchian WA; Horiguchi Y; Nair SK; Fair WR; Heston WD; Gilboa E
Clin Cancer Res; 2000 Jul; 6(7):2913-20. PubMed ID: 10914741
[TBL] [Abstract][Full Text] [Related]
17. Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model.
Horiguchi Y; Larchian WA; Kaplinsky R; Fair WR; Heston WD
Gene Ther; 2000 May; 7(10):844-51. PubMed ID: 10845722
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
